Search

Your results

Showing 10 of 144 results

The rapid growth of genetic databases worldwide, coupled with fast-decreasing costs and the rapid pace of technological change, has increased the possibility of every human genome on Earth being sequenced this century. This raises ethical and legal questions on data privacy and ownership. While a global genetic database would revolutionise preventive medicine and research, new forms of surveillance, discrimination and power imbalances could emerge. The global interplay between the individual, the ...

This At a glance note summarises the study on Relaunching transport and tourism in the EU after COVID-19: Public transport

The outbreak of COVID-19 has had a marked impact on workplaces and reshaped working conditions in the EU. The study explores the impact of COVID-19 on the occupational safety and health of European workers. It presents a review of the measures adopted by 10 selected Member States and an evaluation of the preparedness of the European OSH legal framework for pandemic crises. Based on these findings, the study presents conclusions and policy recommendations.

The outbreak of COVID-19 has had a marked impact on workplaces and reshaped working conditions in the EU. The study explores the impact of COVID-19 on the occupational safety and health of European workers. It presents a review of the measures adopted by 10 selected Member States and an evaluation of the preparedness of the European OSH legal framework for pandemic crises. Based on these findings, the study presents conclusions and policy recommendations.

During the February plenary session, Parliament is expected to debate the final report of its Special Committee on Beating Cancer, and vote on a series of recommendations, calling for specific policy measures in this crucial area of public health.

The Carcinogens and Mutagens Directive is being updated for the fourth time, as part of the fight against cancer and to protect the health of workers in a number of industries. A trilogue agreement on the proposal sets new exposure limits for a range of hazardous substances. The European Parliament is expected to vote on the provisional agreement during its plenary session in February.

Scientific evidence indicates that beneficial microorganisms (that live in nearly ubiquitous communities called microbiota) are an essential component of human health, and could be a new frontier for personalised medicine to fight non-communicable diseases and improve human health. For their potential benefits to reach society, the EU should consider standardisation, protocols, and a regulatory framework to support research and innovation.

The outbreak of the coronavirus pandemic in March 2020 presented parliamentary institutions around the world with a new and unprecedented scenario. Parliamentary rules of procedure in representative democracies are commonly built upon the principles of pluralism, deliberation and transparency, aiming to provide an arena in which representatives of the people have the opportunity to publicly confront each other's points of view in a free and fair setting. It is, therefore, safe to say that ordinary ...

Xenotransplantation, defined as the transplantation of animal derived organs and cells into humans, is currently a very active focus of research as it overrides some of the obstacles encountered with tissue engineering, such as vascularization and innervation. The resurgence of interest in xenotransplantation is mainly attributed to the improvement of gene editing techniques (such as CRISPR/Cas9), since genetically engineered animals have been generated to overcome organ rejection. However, xenotransplantation ...

As part of building a European Health Union, as well as in response to the Covid 19 pandemic, the European Commission proposed in November 2020 to reinforce the European Medicines Agency's role in crisis preparedness and the management of medicines and medical devices. The proposed regulation seeks to better anticipate possible shortages and to ensure timely development of high-quality medicinal solutions, to allow the EU to react to health crises more quickly, efficiently, and in a coordinated manner ...